| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
01-17-2020, 08:55 PM
|
#1 | ||
|
|||
|
Member
|
CPT article: Ambroxol in Parkinson's: Results of Phase ll Trial Published
Ambroxol in Parkinson's: Results of Phase ll Trial Published | The Cure Parkinson's Trust Research paper (open access): Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations - A Nonrandomized, Noncontrolled Trial Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial | Genetics and Genomics | JAMA Neurology | JAMA Network SoPD blog post from Simon: The Ambroxol Results The Ambroxol Results | The Science of Parkinson's |
||
|
 Reply With Quote
|
| Reply |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| SoPD blog post from Simon previewing clinical trials due to report results in 2020 | Parkinson's Disease | |||
| SoPD blog post from Simon: PD research in 2019 - things to look out for this year | Parkinson's Disease | |||
| Masitinib Phase III Clinical Trial Results In For ALS | ALS News & Research | |||
| NurOwn Phase 2 Clinical Trial Results Promising, BrainStorm Cell Reports | ALS News & Research | |||
Ambroxol-for-PD Phase 2 clinical trial (AiM-PD) results published (+ SoPD blog post)
Linear Mode
